| 21-May-13 10:30AM | Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical Officer Business Wire |
| 16-May-13 10:21AM | Oxygen Biotherapeutics Receives Favorable NASDAQ Listing Decision Business Wire -6.96% |
| 03:28AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 15-May-13 09:24AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Oth EDGAR Online |
| 10-May-13 01:09PM | InPlay: Oxygen Biotherapeutics announces 20:1 reverse stock split effective after market close on May 10th Briefing.com |
| 01:09PM | Oxygen Biotherapeutics Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th Business Wire |
| 01-May-13 09:15AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online -6.80% |
| 30-Apr-13 08:01AM | Oxygen Biotherapeutics to begin enrollment in second cohort of STOP-TBI trial at theflyonthewall.com |
| 08:00AM | Oxygen Biotherapeutics Announces It is Set to Begin Enrolling Patients in the Second Cohort of Its STOP-TBI Clinical Trial in Israel Business Wire |
| 05-Apr-13 10:09AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o EDGAR Online |
| 22-Mar-13 01:04PM | OXYGEN BIOTHERAPEUTICS, INC. Financials EDGAR Online Financials |
| 21-Mar-13 09:16AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o EDGAR Online |
| 19-Mar-13 11:00AM | Oxygen Biotherapeutics, Inc. Earnings Call scheduled for 11:00 am ET today CCBN |
| 04:16AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online |
| 12:34AM | Oxygen Biotherapeutics, Inc. Earnings Call scheduled for 11:00 am ET today CCBN |
| 18-Mar-13 05:31PM | Oxygen Biotherapeutics Reports Financial Results for the Third Quarter FY2013 Business Wire |
| 09:30AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:07AM | Q3 2013 Oxygen Biotherapeutics, Inc. Earnings Release - Time Not Supplied CCBN |
| 14-Mar-13 04:25PM | Thursday movers: Apple up 1% ahead of Samsung show at MarketWatch +6.87% |
| 01:40PM | Thursday movers: EBay recovers from steep selloff at MarketWatch |
| 12:23PM | Thursday movers: Apple up ahead of Samsung event at MarketWatch |
| 10:55AM | Thursday movers: Ackman steps up Herbalife seige at MarketWatch |
| 08:07AM | Thursdays movers: Mens Wearhouse, E*Trade at MarketWatch |
| 13-Mar-13 04:45PM | Oxygen Biotherapeutics Announces Third Quarter FY2013 Financial Results Conference Call and Webcast Business Wire -9.34% |
| 08-Mar-13 02:14PM | 5 Stocks Ready to Break Out at TheStreet +19.12% |
| 27-Feb-13 05:27PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online |
| 25-Feb-13 06:02AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ EDGAR Online |
| 22-Feb-13 09:00AM | Oxygen Biotherapeutics raise $2.1M in sale of preferred stock to investor theflyonthewall.com -33.00% |
| 08:59AM | InPlay: Oxygen Biotherapeutics Enters into Definitive Agreements for Financing for up to $2.1 Million in Gross Proceeds Briefing.com |
| 08:58AM | Oxygen Biotherapeutics Enters into Definitive Agreements for Financing for up to $2.1 Million in Gross Proceeds Business Wire |
| 20-Feb-13 11:05AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 11:04AM | InPlay: Oxygen Biotherapeutics announces tentative settlement of litigation; tentative agreement provides that the co will settle the matter for $600,000 in cash Briefing.com |
| 11:03AM | Oxygen Biotherapeutics Announces Tentative Settlement of Litigation Business Wire |
| 11-Feb-13 05:19PM | InPlay: Oxygen Biotherapeutics enters License and Supply agreement for Dermacyte products with the cosmetics division of Valor SA Briefing.com -10.34% |
| 05:15PM | Oxygen Biotherapeutics Enters License and Supply Agreement for Dermacyte® Products with the Cosmetics Division of Valor SA Business Wire |
| 05:01PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events EDGAR Online |
| 06-Feb-13 08:30AM | Oxygen Biotherapeutics and the U.S. Army Institute of Surgical Research Sign a Cooperative Research and Development Agreement to Study the Effects of Oxycyte® on Ex Vivo Platelet Function Business Wire -8.57% |
| 30-Jan-13 08:28PM | Oxygen Biotherapeutics Announces It Will Present at the 15th Annual BIO CEO & Investor Conference on February 11 Business Wire |
| 08:30AM | Oxygen Biotherapeutics Announces It Will Present at the 15th Annual BIO CEO & Investor Conference on February 11 Business Wire |
| 08-Jan-13 08:44PM | Oxygen Biotherapeutics Announces It Will Present at OneMedForum Conference on Wednesday January 9th Business Wire |
| 20-Dec-12 01:04PM | OXYGEN BIOTHERAPEUTICS, INC. Financials EDGAR Online Financials |
| 17-Dec-12 08:21AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online -7.92% |
| 07:15AM | Oxygen Biotherapeutics Reports Second Quarter FY2013 Financial Results Business Wire |
| 14-Dec-12 04:39PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09:24AM | New Stock Coverage: Microsoft Still Has Major Issues at Minyanville |
| 07:07AM | Q2 2013 Oxygen Biotherapeutics, Inc. Earnings Release - Time Not Supplied CCBN |
| 05:30AM | Big earnings Friday: Ricks Cabaret, Ocean Power at MarketWatch |
| 06-Dec-12 02:43PM | Oxygen Biotherapeutics Announces Second Quarter FY2013 Financial Results Conference Call and Webcast Business Wire |
| 20-Nov-12 10:31AM | PPD to test Oxygen Biotherapeutics drug at bizjournals.com |
| 08:30AM | Oxygen Biotherapeutics Engages PPD to Execute Remainder of Phase IIb Clinical Trial to Evaluate the Safety and Tolerability of Oxycyte® in Severe Traumatic Brain Injury Business Wire |
| 26-Oct-12 06:58AM | Oxygen trying to get proposed drug back on track at bizjournals.com |
| 25-Oct-12 05:02PM | Oxygen trying to get proposed drug back on track at bizjournals.com |
| 08:06AM | InPlay: Oxygen Biotherapeutics' update on U.S. Army-funded preclinical studies designed to support the safety profile of Oxycyte PFC emulsion currently in clinical trials overseas for traumatic brain injury Briefing.com |
| 08:00AM | Oxygen Biotherapeutics Update on U.S. Army-Funded Preclinical Studies Designed to Support the Safety Profile of Oxycyte PFC Emulsion Currently in Clinical Trials Overseas for Traumatic Brain Injury Business Wire |
| 08-Oct-12 01:51PM | Delisting danger deja vu for Oxygen Biotherapeutics at bizjournals.com -8.68% |
| 05-Oct-12 04:31PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o EDGAR Online +11.36% |
| 03-Oct-12 08:05AM | InPlay: Oxygen Biotherapeutics signs cooperative research and development agreement with U.S. navy to investigate the use of Oxycyte PFC emulsion as an adjunctive treatment of complex infected wounds and related injuries Briefing.com +16.36% |
| 08:02AM | Oxygen Biotherapeutics signs R&D agreement with U.S. Navy at theflyonthewall.com |
| 08:00AM | Oxygen Biotherapeutics Signs Cooperative Research and Development Agreement with U.S. Navy to Investigate the Use of Oxycyte PFC Emulsion as an Adjunctive Treatment of Complex Infected Wounds and Related Injuries Business Wire |
| 25-Sep-12 01:04PM | OXYGEN BIOTHERAPEUTICS, INC. Financials EDGAR Online Financials |
| 21-Sep-12 10:00AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o EDGAR Online |
| 20-Sep-12 06:02AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online |
| 19-Sep-12 05:30PM | Oxygen Biotherapeutics Reports First Quarter FY2013 Financial Results Business Wire -6.84% |
| 04:58PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:07AM | Q1 2013 Oxygen Biotherapeutics, Inc. Earnings Release - Time Not Supplied CCBN |
| 17-Sep-12 10:33AM | Oxygen Biotherapeutics Announces First Quarter FY2013 Financial Results Conference Call and Webcast Business Wire |
| 07-Sep-12 05:04PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 29-Aug-12 07:17AM | InPlay: Oxygen Biotherapeutics relocating R&D function to North Carolina from California; successfully subleased its Costa Mesa facility at terms that made the transition cost effective Briefing.com |
| 28-Aug-12 05:02PM | Oxygen Biotherapeutics relocating R&D function to North Carolina at theflyonthewall.com |
| 05:00PM | Oxygen Biotherapeutics Relocating R&D Function to North Carolina from California Business Wire |
| 04:35PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 21-Aug-12 07:02AM | InPlay: Oxygen Biotherapeutics: University of Glasgow study demonstrates the ability of Oxycyte to supply oxygen to critical penumbral tissue in acute ischemic stroke Briefing.com -7.84% |
| 07:00AM | University of Glasgow Study Demonstrates the Ability of Oxycyte® to Supply Oxygen to Critical Penumbral Tissue in Acute Ischemic Stroke Business Wire |
| 02-Aug-12 08:02AM | InPlay: Oxygen Biotherapeutics and U.S. Navy expand collaboration with Cooperative Research & Development Agreement Briefing.com |
| 08:00AM | Oxygen Biotherapeutics and U.S. Navy Expand Collaboration with Cooperative Research & Development Agreement to Study Oxycyte® for Treatment of Hemorrhagic Shock Business Wire |
| 28-Jul-12 01:04PM | OXYGEN BIOTHERAPEUTICS, INC. Financials EDGAR Online Financials |
| 25-Jul-12 11:00AM | Oxygen Biotherapeutics Inc Earnings Call scheduled for 11:00 am ET today CCBN |
| 10:46AM | Oxygen Biotherapeutics Inc Earnings Call scheduled for 11:00 am ET today CCBN |
| 06:03AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online |
| 06:03AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-K, Annual Report EDGAR Online |
| 24-Jul-12 06:33PM | Oxygen Biotherapeutics Reports Financial Results for Fiscal Year 2012 Business Wire |
| 07:07AM | Q4 2012 Oxygen Biotherapeutics, Inc. Earnings Release - Time Not Supplied CCBN |
| 28-Jun-12 01:30PM | Oxygen Biotherapeutics Sets Year-End Financial Results Conference Call and Webcast for July 25th and General Annual Meeting for August 31st GlobeNewswire |
| 15-Jun-12 08:08AM | InPlay: Oxygen Biotherapeutics announces expected closing on second installment of Dec 2011 financing and amends agreement to allow for a third tranche later this year pending shareholder approval Briefing.com -10.87% |
| 08:05AM | Oxygen Biotherapeutics Announces Expected Closing on Second Installment of December 2011 Financing and Amends Agreement to Allow for a Third Tranche Later This Year Pending Shareholder Approval GlobeNewswire |
| 08:02AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial EDGAR Online |
| 31-May-12 09:39AM | InPlay: Oxygen Biotherapeutics study reveals Dermacyte concentrate's potential to relieve histamine-induced pruritus in healthy patients Briefing.com +5.79% |
| 09:38AM | Oxygen Biotherapeutics Study Reveals Dermacyte(R) Concentrate's Potential to Relieve Histamine-Induced Pruritus in Healthy Patients GlobeNewswire |
| 03-May-12 10:49AM | InPlay: Oxygen Biotherapeutics secures long-term clinical supply of Oxycyte Briefing.com |
| 10:47AM | Oxygen Biotherapeutics Secures Long-Term Clinical Supply of Oxycyte(R) GlobeNewswire |
| 12-Apr-12 04:56PM | Health Care Sector Wrap at Fox Business -7.73% |
| 22-Mar-12 01:04PM | OXYGEN BIOTHERAPEUTICS, INC. Financials EDGAR Online Financials |
| 16-Mar-12 11:00AM | Oxygen Biotherapeutics Inc Earnings Call scheduled for 11:00 am ET today CCBN |
| 06:05AM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online |
| 15-Mar-12 10:21PM | Oxygen Biotherapeutics Reports Financial Results for the Third Quarter FY2012 GlobeNewswire |
| 05:17PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:07AM | Q3 2012 Oxygen Biotherapeutics, Inc. Earnings Release - Time Not Supplied CCBN |
| 01-Mar-12 04:46PM | InPlay: Oxygen Biotherapeutics announces plan to regionalize its sales & marketing efforts for its dermacyte oxygenating skin care product line Briefing.com |
| 04:44PM | Oxygen Biotherapeutics Announces Plan to Regionalize Its Sales & Marketing Efforts for Its Dermacyte(R) Oxygenating Skin Care Product Line GlobeNewswire |
| 04:18PM | OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online |
